Chardonnay Marc for Gut and Cardiometabolic Health
This study is looking at how eating Chardonnay Marc, which are the skins and seeds of Chardonnay grapes, might affect your gut and heart health. Researchers want to see if this food product, rich in natural plant compounds called flavanols, can help improve your health. You might be able to join if you are a postmenopausal woman between 45 and 70 years old, have a BMI between 25 and 49.9 kg/m2, and have fasting triglycerides (a type of fat in the blood) above 120 mg/dL. The main goal is to see how Chardonnay Marc affects microvascular function (how well your small blood vessels work) after 12 weeks. The current status of this study is unclear, and it plans to enroll 5 participants.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention (Chardonnay Marc). It is a small pilot study planning to enroll 5 women.
- What's involved
- You would have 3 study visits over 12 weeks. At each visit, about 3.5 tablespoons of blood will be collected. You will eat Chardonnay Marc daily for 12 weeks, starting with 1.5g for the first 6 weeks and increasing to 4.5g for the remaining 6 weeks, and log your intake.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 weeks, with microvascular function measured at the end of this period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Microvascular function12 weeks
Microvascular function measured by peripheral arterial tonometry